E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Thomas Jefferson University
Sichuan Enray Pharmaceutical Sciences Company
University of Alabama at Birmingham
UNICANCER
Indiana University
Barbara Ann Karmanos Cancer Institute
Ohio State University Comprehensive Cancer Center
Afyonkarahisar Health Sciences University
Shanghai Bovax Biotechnology Co., Ltd.
M.D. Anderson Cancer Center
University of Pittsburgh
University of Manchester
Peking Union Medical College Hospital
Dana-Farber Cancer Institute
Beijing Health Guard Biotechnology, Inc
Beijing Health Guard Biotechnology, Inc
Institut de Cancérologie de Lorraine
Xencor, Inc.
Ohio State University Comprehensive Cancer Center
NRG Oncology
Shanghai Bovax Biotechnology Co., Ltd.
St.Gallen University of Applied Sciences
Institut de Cancérologie de Lorraine
GOG Foundation
Women's College Hospital
Institute of Cancer Research, United Kingdom
Abramson Cancer Center at Penn Medicine
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Boston Medical Center
Albert Einstein College of Medicine
University of Michigan
Alliance for Clinical Trials in Oncology
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Memorial Sloan Kettering Cancer Center
Ohio State University Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
GOG Foundation
Oryx GmbH & Co. KG
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Merck Sharp & Dohme LLC
St.Gallen University of Applied Sciences